EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis

Zachary A Yetmar iD, Ryan B Khodadadi iD, Supavit Chesdachai iD, Jack W McHugh iD, Douglas W Challener iD, Nancy L Wengenack iD, Wendelyn Bosch iD, Maria Teresa Seville iD, Elena Beam iD

Open Forum Infectious Diseases · 28.03.2024 · 11 (4)

DOI: 10.1093/ofid/ofae122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 01.03.2024. Verfasst von Zachary A Yetmar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nocardia tends to cause infection in immunocompromised patients or those with chronic pulmonary disease. Nocardia is known to recur, prompting the practice of secondary prophylaxis in patients perceived at high risk. However, few data exist regarding the epidemiology of recurrent nocardiosis or the effectiveness of secondary prophylaxis.

Methods

We performed a multicenter, retrospective cohort study of adults diagnosed with nocardiosis from November 2011 to April 2022, including patients who completed primary treatment and had at least 30 days of posttreatment follow-up. Propensity score matching was used to analyze the effect of secondary prophylaxis on Nocardia recurrence.

Results

Fifteen of 303 (5.0%) patients developed recurrent nocardiosis after primary treatment. Most recurrences were diagnosed either within 60 days (N = 6/15, 40.0%) or between 2 to 3 years (N = 4/15, 26.7%). Patients with primary disseminated infection tended to recur within 1 year, whereas later recurrences were often nondisseminated pulmonary infection. Seventy-eight (25.7%) patients were prescribed secondary prophylaxis, mostly trimethoprim-sulfamethoxazole (N = 67/78). After propensity-matching, secondary prophylaxis was not associated with reduced risk of recurrence (hazard ratio, 0.96; 95% confidence interval, .24–3.83), including in multiple subgroups. Eight (53.3%) patients with recurrent nocardiosis required hospitalization and no patients died from recurrent infection.

Conclusions

Recurrent nocardiosis tends to occur either within months because of the same Nocardia species or after several years with a new species. Although we did not find evidence for the effectiveness of secondary prophylaxis, the confidence intervals were wide. However, outcomes of recurrent nocardiosis are generally favorable and may not justify long-term antibiotic prophylaxis for this indication alone.

Schlagwörter

Stichwörter der Autor:innen

Nocardiabronchiectasisreinfectionrelapsetrimethoprim-sulfamethoxazole

Autor:innen und Institutionen

  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA.
  • Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA.
  • Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Zachary A Yetmar, Ryan B Khodadadi, Supavit Chesdachai, Jack W McHugh, Douglas W Challener, Nancy L Wengenack, Wendelyn Bosch, Maria Teresa Seville, Elena Beam

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Yetmar, Z. A., Khodadadi, R. B., Chesdachai, S., McHugh, J. W., Challener, D. W., Wengenack, N. L., Bosch, W., Seville, M. T., & Beam, E. (2024). Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infectious Diseases, 11(4). https://doi.org/10.1093/ofid/ofae122

Vancouver

Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, et al. Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infectious Diseases. 2024;11(4). doi:10.1093/ofid/ofae122

BibTeX
@article{Yetmar2024,
  author = {Yetmar, Zachary A and Khodadadi, Ryan B and Chesdachai, Supavit and McHugh, Jack W and Challener, Douglas W and Wengenack, Nancy L and Bosch, Wendelyn and Seville, Maria Teresa and Beam, Elena},
  title = {Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {4},
  doi = {10.1093/ofid/ofae122}
}
Kostenlos starten →